Zobrazeno 1 - 10
of 495
pro vyhledávání: '"Ninou I"'
Publikováno v:
In Energy Policy 2011 39(5):2512-2527
Autotaxin (ATX) is secreted by various type of cells in health and disease and catalyzes the extracellular production of lysophosphatidic acid (LPA). In turn, LPA is a bioactive lysophospholipid promoting a wide array of cellular functions through it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4df2a0d5c916369c4ff4c9db04610d
https://doi.org/10.1101/2020.01.17.910141
https://doi.org/10.1101/2020.01.17.910141
Background: Vitamin D (VitD) is a steroid hormone with cytoprotective and anti-inflammatory properties. Epidemiological studies have suggested a link between VitD deficiency and risk of development of chronic lung diseases. Its role in lung fibrosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::0787db7b5d76d3d5e1d9fc10b844c0b8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122430
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3122430
Pulmonary fibrosis is a progressive disease characterized by disruption of lung architecture and deregulation of the pulmonary function. Prostacyclin, a metabolite of arachidonic acid, is a potential disease mediator since it exerts anti-inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::a1673b681194d6be8de30e02da9ff5a2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105578
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3105578
Autotaxin (ATX) catalyzes the hydrolysis of lysophosphatidylcholine (LPC) generating the lipid mediator lysophosphatidic acid (LPA). Both ATX and LPA are involved in various pathological inflammatory conditions, including fibrosis and cancer, and hav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::52e049958fe415f76cf7ffea3175c28a
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3021704
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3021704
Idiopathic pulmonary fibrosis (IPF) is an inexorably progressive lung disease of unknown origin. Prognosis is poor, with limited treatment options available, and the median survival remains just 3-5 years. Despite the use of pirfenidone and nintedani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::ddf42985fc0226ef4cd23643abcc99ce
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107420
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3107420
Autor:
Nikitopoulou I; 1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece., Ninou I; Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Athens, Greece., Manitsopoulos N; 1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece., Dimopoulou I; 1st Department of Critical Care Medicine & Pulmonary Services, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece., Orfanos SE; 1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece.; 2nd Department of Critical Care, National and Kapodistrian University of Athens Medical School, Attikon' Hospital, Athens, Greece., Aidinis V; Institute of Immunology, Biomedical Sciences Research Center Alexander Fleming, Athens, Greece., Kotanidou A; 1st Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece. akotanid@med.uoa.gr.; 1st Department of Critical Care Medicine & Pulmonary Services, National and Kapodistrian University of Athens Medical School, Evangelismos Hospital, 45, Ipsilantou Street, Athens, Greece. akotanid@med.uoa.gr.
Publikováno v:
Intensive care medicine experimental [Intensive Care Med Exp] 2021 Mar 29; Vol. 9 (1), pp. 12. Date of Electronic Publication: 2021 Mar 29.
Autor:
Enzel, Darya1 (AUTHOR) darya.enzel@yandex.ru, Kriventsov, Maxim1 (AUTHOR), Sataieva, Tatiana1 (AUTHOR) tanzcool@mail.ru, Malygina, Veronika1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8946. 20p.
Autor:
Laface, Carmelo1 (AUTHOR) carmelo.laface@irccsdebellis.it, Ricci, Angela Dalia1 (AUTHOR), Vallarelli, Simona1 (AUTHOR), Ostuni, Carmela1 (AUTHOR), Rizzo, Alessandro2 (AUTHOR), Ambrogio, Francesca3 (AUTHOR), Centonze, Matteo4 (AUTHOR) matteo.centonze@irccsdebellis.it, Schirizzi, Annalisa5 (AUTHOR) annalisa.schirizzi@irccsdebellis.it, De Leonardis, Giampiero5 (AUTHOR) giampiero.deleonardis@irccsdebellis.it, D'Alessandro, Rosalba5 (AUTHOR), Lotesoriere, Claudio1 (AUTHOR) carmelo.laface@irccsdebellis.it, Giannelli, Gianluigi6 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 14, p7737. 26p.
Autor:
Lebel, Mégane1 (AUTHOR) megane.lebel@usherbrooke.ca, Cliche, Dominic O.1 (AUTHOR) dominic.cliche@usherbrooke.ca, Charbonneau, Martine2 (AUTHOR) martine.charbonneau@usherbrooke.ca, Brochu-Gaudreau, Karine2 (AUTHOR) karine.brochu-gaudreau@usherbrooke.ca, Adam, Damien3 (AUTHOR) damien.adam@umontreal.ca, Brochiero, Emmanuelle3,4 (AUTHOR) emmanuelle.brochiero@umontreal.ca, Dubois, Claire M.2 (AUTHOR) claire.dubois@usherbrooke.ca, Cantin, André M.1 (AUTHOR) andre.cantin@usherbrooke.ca
Publikováno v:
Cells (2073-4409). Jul2024, Vol. 13 Issue 13, p1152. 18p.